A single payer system removes greed from a place it certainly has no place. Healthcare should be constructed of an ambition to heal, not a hunger for money. Our greed driven system is dangerous, and is resulting in the death of our people. Read more
Why is this happening? How are millions of people slipping through the cracks? Why are we living in fear because we cannot afford to “breathe”? Insulin is oxygen; price gouging cannot go on. This is my plea—our plea— and we are in desperate need of change. Read more
My reality as a type 1 diabetic is undoubtedly tough, living in a remote, developing nation. I’ve rationed insulin and testing strips on multiple occasions, not knowing when exactly I’ll have access to these essential supplies... Read more
We call upon the Government of Canada to clarify whether or not type 1 diabetes qualifies for the Disability Tax Credit program, and for the government to remove all unnecessary barriers to insulin and supply access for people with diabetes. We support calls for the creation of a national universal pharmacare program, a frequently stated priority of the Canadian government, and note such a program would render this entire debate moot. Read more
The one thing I know about in life is change. I was 12 turning 13 when my father got sick and died. He had been diagnosed with an enlarged heart and was awaiting a heart transplant, so we travelled from Canada down to the United States for him to say goodbye to the rest of the family. It was our last night there, and he didn't make it. Read more
I joined dozens of people impacted by the rising cost of insulin in the USA in protest of those prices in front of Eli Lilly headquarters in Indianapolis, Indiana. Some had traveled many hours to join the protest, but one thing was made clear, we wanted to ensure that Eli Lilly heard our voices. We were passionate in our outcry for change and jointly understood that not saying anything is simply not an option.
Patients and those who support us will be demonstrating outside of Eli Lilly HQ in Indianapolis on Saturday, September 9th 2017. See the full post for more information and join us at https://www.facebook.com/groups/insulin4allAction/ if you can be there.
As insulin prices crept upward, I realized I needed to figure out more ways to increase my sensitivity and reduce the large load of insulin I had to pump into myself every day. It became more than a financial struggle; I was scared that synthetic insulin could become insufficient. Then what? So with my shallow pockets and fear for the future, I talked with my doctor about the type two medication, Metformin. Read more
In the wake of rising insulin prices in the United States and recent threats to public health safety nets like Medicaid, patients with type 1 diabetes are becoming increasingly more vulnerable. As a member of the T1D community and a rising second year Masters student at the Yale School of Public Health, Samantha Willner is hoping to shed light on the terrible sacrifices members of the T1D community in the U.S. have had to make in order to get the medicine they need to live. Read more
Sixteen organisations have signed an open letter to Dr. Tedros Adhanom Ghebreyesus, the incoming Director-General of the World Health Organization. The letter, penned by T1International, praises his attention to diabetes and requests that more focus is put on access to insulin and treatment for everyone living with diabetes around the world. Read more